This is a preview of subscription content, log in via an institution to check access.
Notes
The study was partially funded by Merck Sharp & Dohme, Colombia.
Reference
Rodriguez-Martinez CE, et al. Cost-Effectiveness Analysis of Mometasone Furoate Versus Beclomethasone Dipropionate for the Treatment of Pediatric Allergic Rhinitis in Colombia. Advances in Therapy : 10 Mar 2015. Available from: URL: http://doi.org/10.1007/s12325-015-0192-6
Rights and permissions
About this article
Cite this article
Mometasone preferred option in paediatric allergic rhinitis. PharmacoEcon Outcomes News 724, 19 (2015). https://doi.org/10.1007/s40274-015-1997-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-1997-x